- March 17, 2023
Welldoc's President and CEO, Kevin McRaith, is quoted in the "Scrip Asks" column, which highlights perspectives from corporate leaders on what 2023 holds therapeutic advances in the biopharma industry....
- September 28, 2022
Welldoc is featured by Insightscare and named one of the “10 Most Trusted Diabetes Solution Providers in 2022.”...
- September 19, 2022
Welldoc is featured by The Healthcare Insights and named "Company of the Year 2022."...
- May 24, 2022
Welldoc is featured by CIO Review and named "Most Promising Healthcare Solutions Provider 2022."...
- May 12, 2022
The Wall Street Journal's Pro Venture Capital features Welldoc and CEO and President Kevin McRaith. The article highlights Welldoc's leadership in the digital health and digital therapeutics space, and ability to continually adapt its business model and product offerings to meet the evolving healthcare market....
- May 2, 2022
The Economist features Welldoc and BlueStar®, our FDA-cleared digital health solution, in their Technology Quarterly edition on how digital health is rapidly becoming an integral part of health care....
